title: Infliximab: a promising alternative therapy for refractory arthritis/urethritis/conjunctivitis triad.
authors.affiliation: Rheumatology Division, Faculty of Medicine, University of Sao Paulo, and Center for High Cost Medicines (CEDMAC), Sao Paulo, Brazil.
authors.forename: Jozélio Freire
authors.initials: JF
authors.lastname: de Carvalho
authors.forename: Ana Cristina de Medeiros
authors.initials: AC
authors.lastname: Ribeiro
authors.forename: Júlio Cezar Bertacini
authors.initials: JC
authors.lastname: de Moraes
authors.forename: Carla
authors.initials: C
authors.lastname: Gonçalves
authors.forename: Cláudia
authors.initials: C
authors.lastname: Goldenstein-Schainberg
authors.forename: Eloísa
authors.initials: E
authors.lastname: Bonfá
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016918:Arthritis, Reactive / Q000150:complications / Q000188:drug therapy*; D003231:Conjunctivitis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D014526:Urethritis / Q000150:complications / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab